India is among the countries hardest hit by "antimicrobial resistance". In 2019 alone, antibiotic-resistant infections caused ...

India has introduced its first indigenous antibiotic, Nafithromycin, targeting drug-resistant pneumonia. The drug is 10 times ...

A research team have recently published their article, "Rationally designed pooled CRISPRi-seq uncovers an inhibitor of ...

According to the U.S. Food and Drug Administration, there isn’t evidence to show that over-the-counter (OTC) antibacterial ...

Discover Nafithromycin Indias first indigenous antibiotic revolutionising the fight against drug-resistant pneumonia with ...

Habil Khorakiwala, Chairman of Wockhardt had previously said that once the trials are complete, the company will seek ...

India has developed a new antibiotic, nafithromycin (Miqnaf), to combat drug-resistant pneumonia. Developed by Wockhardt with ...